These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 541682)

  • 21. Tubular forms of hepatitis B surface antigen bind with the nucleus of 22-nm spherical HBsAg particles.
    Mishiro S; Imai M; Gotanda T; Takahashi K; Sano T; Yoshizawa H; Miyakawa Y; Mayumi M
    J Med Virol; 1981; 6(4):269-78. PubMed ID: 7241094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dane particle DNA polymerase and HBeAg: impact on clinical, laboratory, and histologic findings in hepatitis B-associated chronic liver disease.
    Andres LL; Sawhney VK; Scullard GH; Smith JL; Merigan TC; Robinson WS; Gregory PB
    Hepatology; 1981; 1(6):583-5. PubMed ID: 7308991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Classification and infectiousness of chronic hepatitis B, defined by the Dane particle in the blood and virus components in the liver].
    Gudat F; Bianchi L; Stalder GA; Schmid M
    Schweiz Med Wochenschr; 1976 Jun; 106(24):812-24. PubMed ID: 792997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
    Perrillo R; Campbell C; Wellinghoff W; Gelb L
    Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection.
    Alberti A; Diana S; Sculard GH; Eddleston AL; Williams R
    Br Med J; 1978 Oct; 2(6144):1056-8. PubMed ID: 81702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.
    Chadwick RG; Bassendine MF; Crawford EM; Thomas HC; Sherlock S
    Br Med J; 1978 Aug; 2(6136):531-3. PubMed ID: 698557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative correlation between the Dane particle-associated DNA polymerase and the hepatitis B e antigen.
    Siegert W; Grunst J; Wilmanns W; Frösner GG; Deinhardt F
    Infection; 1979; 7(5):220-2. PubMed ID: 511339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Independence of the appearance of HBsAg in the saliva and blood serum].
    Nimadava P; Tsatsral Kh; Oiuunbileg Zh; Anan'ev VA; Dolgor M
    Vopr Virusol; 1988; 33(2):173-5. PubMed ID: 3414066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of hepatitis B surface antigen in the saliva of patients with acute hepatitis B, and of chronic carriers.
    Wong ML; Lehmann NI; Gust ID
    Med J Aust; 1976 Jul; 2(2):52-5. PubMed ID: 979797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of soluble DNA polymerase from sera of hepatitis B virus carriers.
    Mao JC; Otis ER; Mushahwar IK; Overby LR
    J Med Virol; 1981; 6(4):285-99. PubMed ID: 7241096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B antigen in saliva, urine, and stool.
    Irwin GR; Allen AM; Bancroft WH; Karwacki JJ; Brown HL; Pinkerton RH; Willhight M; Top FH
    Infect Immun; 1975 Jan; 11(1):142-5. PubMed ID: 1116873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver enzyme concentrations as measure of possible infectivity in chronic asymptomatic carriers of hepatitis B.
    Barbara JA; Mijovic V; Cleghorn TE; Tedder RS; Briggs M
    Br Med J; 1978 Dec; 2(6152):1600-2. PubMed ID: 728740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
    Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
    Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
    Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
    Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays.
    Mushahwar IK; Overby LR; Frosner G; Deinhardt F; Ling CM
    J Med Virol; 1978; 2(2):77-87. PubMed ID: 670950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of hepatitis-B-virus by pleural effusion containing Dane particles.
    Hess G; Dienes HP; Hess A; Arnold W; Meyer zum Bäuschenfelde KH
    Hepatogastroenterology; 1981 Jun; 28(3):151-4. PubMed ID: 7250895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan.
    Stevens CE; Neurath RA; Beasley RP; Szmuness W
    J Med Virol; 1979; 3(3):237-41. PubMed ID: 479860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of hepatitis B e antigen for a long period after the clearance of hepatitis B surface antigen.
    Tamura I; Shimase K; Ichimura H; Kurimura O; Kaneto E; Tsuchie H; Kurimura T
    Acta Virol; 1985 Dec; 29(6):505-8. PubMed ID: 2869663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphological makeup of the structures containing HBsAg in the blood of acute and chronic serum hepatitis patients].
    Shumkina OB; Sinaĭko GA; Paktoris EA
    Vopr Virusol; 1979; (2):148-51. PubMed ID: 433242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.